Brian Rini, MD, FASCO

Brian I. Rini, MD, FASCO, is Ingram Professor of Medicine and Chief of Clinical Trials at Vanderbilt-Ingram Cancer Center in Nashville, Tennessee, and co-host of The Uromigos podcast.

Articles by Brian Rini, MD, FASCO

Brian Rini, MD, FASCOVideo Insights | March 16, 2023
In the final segment of a debate series, Brian Rini, MD, and Monty Pal, MD, debate RCC adjuvant therapeutic options.
View More
Brian Rini, MD, FASCORoundtable | March 15, 2023
The panel shares interesting clinical trial data in development, including CONTACT-03, TiNivo-2, and more.
Brian Rini, MD, FASCORoundtable | March 15, 2023
The panel discusses triplet combinations in development for RCC.
Brian Rini, MD, FASCORoundtable | March 15, 2023
The panel discusses the disappointing results of the COSMIC-313 trial.
Brian Rini, MD, FASCOVideo Insights | March 15, 2023
In the second segment of a debate series, Drs. Rini and Pal address kidney cancer clinical trials of interest.
Brian Rini, MD, FASCORoundtable | March 14, 2023
The panel discusses treatment-related toxicities and when to consider stopping treatment.
Brian Rini, MD, FASCOVideo Insights | March 14, 2023
In a debate series between Brian Rini, MD, and Monty Pal, MD, they discuss frontline RCC treatment options.
Brian Rini, MD, FASCORenal Cell Carcinoma | March 10, 2023
The panel compares three treatment regimens.
Brian Rini, MD, FASCORoundtable | March 10, 2023
The panel discusses the CheckMate 8Y8 clinical trial.
Brian Rini, MD, FASCORoundtable | March 7, 2023
The panel discusses which patients in their practices would be candidates for ipilimumab/nivolumab combination.
Brian Rini, MD, FASCORoundtable | March 6, 2023
The panel discusses monotherapy treatment for RCC.
Brian Rini, MD, FASCORoundtable | March 2, 2023
The panel discusses how they each approach debulking nephrectomy in their RCC patients.
Brian Rini, MD, FASCORenal Cell Carcinoma | March 2, 2023
Dr. Rini discusses front-line immuno-oncology (IO)-based clinical trials in metastatic renal cell carcinoma.
Brian Rini, MD, FASCORoundtable | February 28, 2023
Dr. Rini is joined by a panel of RCC experts to discuss patient characteristics that impact treatment selection.